← Back to Search

Other

Celastrol for Safety

N/A
Waitlist Available
Led By Rubin Patel, MD
Research Sponsored by Legend Labz, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights
No Placebo-Only Group

Summary

This trial tests the safety of Celastrol, a natural compound from a plant, in healthy adults aged 18-40. Celastrol may help reduce inflammation and protect cells from damage. The study will monitor participants for three months to ensure it is safe to use. Celastrol is a natural compound derived from the roots of Tripterygium wilfordii, traditionally used in Chinese medicine for its anti-inflammatory and antioxidant properties.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Liver
Secondary study objectives
ALT (U/L)
SGOT - Glutamate oxaloacetate transaminase
Absolute Basophils (K/UL)
+39 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Amount of Celastrol AdministeredExperimental Treatment1 Intervention
Chronic evaluation of the same doses of Celastrol to each subject over 90-day period

Find a Location

Who is running the clinical trial?

Legend Labz, Inc.Lead Sponsor
1 Previous Clinical Trials
5 Total Patients Enrolled
Rubin Patel, MDPrincipal InvestigatorPatient Plus Urgent Care
1 Previous Clinical Trials
5 Total Patients Enrolled
~10 spots leftby Nov 2025